Nocturia, a condition characterized by waking up multiple times during the night to use the bathroom, occurs in about one-third of men over the age of 30. As they age, men become even more likely to ...

In recent years, a new treatment strategy known as focal therapy (partial gland ablation) has emerged for prostate cancer considered to be "intermediate risk"—mostly, small tumors confined to one area ...

For patients with locally advanced prostate cancer, combined treatment with chemotherapy and hormonal therapy offers extended control of prostate-specific antigen (PSA) levels, compared to hormonal ...

At a median follow-up of 21.5 months, ADT plus apalutamide significantly prolonged median PSA progression-free survival compared with ADT monotherapy (24.9 vs 20.3 months; hazard ratio [HR], 0.52).

In the quest for optimal health, especially concerning prostate wellness, men often find themselves overwhelmed with options that claim to deliver results. This is where Total Control 24 comes into ...

Treatment options for prostate cancer have dramatically expanded. Facing a prostate cancer diagnosis often raises concerns among men and their partners: will treatment affect intimacy and their ...

For men with advanced prostate cancer that no longer responds to standard hormone therapies, treatment options are limited – and time matters. As the disease progresses, the window for effective, less ...

NEWTOWN, Conn., March 31, 2026 /PRNewswire/ -- Elidah today announced FDA clearance of Elitone for Men, a non-invasive, at-home treatment designed to help men regain bladder control after prostate ...

High-intensity focused ultrasound (HIFU) can help some men with prostate cancer avoid surgery or radiation. In recent years, a new treatment strategy known as focal therapy (partial gland ablation) ...